Peter A Thompson - Director, Corvus Pharmaceuticals, Inc
As of September 13, 2021
Peter A Thompson Net Worth
- Net worth is estimated to be at least $884.75M
- Owns at least 6,767,584 units of Corvus Pharmaceuticals, Inc stock
Peter A Thompson Trading
- Largest purchase of shares was 5,258,450 units , worth over $8.25M on March 29, 2016
- In total has made about 17 transactions over 5 years
- Usually trades in June, with the busiest year in 2016
Peter Thompson
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Peter A Thompson Mailing Address
- Mailing address is C/o Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545 CA
Corvus Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 15,000 units bought on April 1, 2022 by Richard A. Miller worth over $24.53K
- In the last 6 years, insiders at Corvus Pharmaceuticals, Inc sold an estimated value of $52.82M and bought an estimated value of $84.02M
- The most active traders are Richard A. Miller, President and CEO, Peter Thompson, Director, and Orbimed Advisors Llc, Director
- Insider trading is most common in June, with the busiest year in 2016
Corvus Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |